Results 151 to 160 of about 8,539 (209)

CEBPD Suppresses Prolactin Expression and Prolactinoma Cell Proliferation

, 2011
Yunguang Tong, Jin Zhou, Jun Mizutani, Hidenori Fukuoka, Song-Guang Ren, Arthur Gutierrez‐Hartmann, H. Phillip Koeffler, Шломо Мелмед   +7 more
openalex   +2 more sources

Outcomes of transsphenoidal surgery in prolactinomas: improvement of hormonal control in dopamine agonist-resistant patients

, 2012
Vanessa Primeau, Christian Raftopoulos, Dominique Maiter   +2 more
openalex   +1 more source

Response to cabergoline treatment, gonadal axis recovery, and outcomes of drug withdrawal, in men with microprolactinoma: a retrospective cohort study. [PDF]

Endocrine
Rudman Y, Simon N, Shimon R, Drozdinsky G, Markus E, Duskin-Bitan H, Masri-Iraqi H, Tsvetov G, Akirov A, Shimon I.   +9 more
europepmc   +1 more source

Aripiprazole use as a cause of dopamine agonist failure in the treatment of prolactinomas. [PDF]

Endocr Oncol
Mignone E, Jukes AK, Valentine R, Allison R, De Sousa SMC.   +4 more
europepmc   +1 more source

Hyperprolactinemia caused by extra-pituitary prolactin secretion: a systematic review. [PDF]

Endocr Connect
Lu Y, Chen X, Ke X, Duan L, Yang H, Pan H, Gong F, Wang L, Zhu H.   +8 more
europepmc   +1 more source

MicroRNA Is Downregulated in Invasive Non-Functioning Pituitary Adenomas. [PDF]

Int J Mol Sci
Derwich-Rudowicz A, Żbikowska A, Ruchała M, Andrusiewicz M, Moskal J, Sawicka-Gutaj N.   +5 more
europepmc   +1 more source

Correction: Giant prolactinoma with progressive cranial settling and central herniation: a case report. [PDF]

J Med Case Rep
Shahbazi T, Abdollahi Yeganeh S, Borzouei S, Arjipour M.   +3 more
europepmc   +1 more source

Gender differences in prolactin thresholds and their association with lactotroph adenoma invasiveness for potential treatment considerations. [PDF]

Sci Rep
Andereggen L, Christ E, Stieger A, Luedi MM, Huber M.   +4 more
europepmc   +1 more source